The microbiome is the collective genetic material of all the microorganisms that inhabit an environment, like the human gut or a particular soil. Eagle Genomics, an England-based company, is developing a platform that uses data about that genetic material to drive innovation.
At yesterday’s special COP26 session on nutrition and health (hosted by the U.N. Climate Change Global Innovation Hub) speakers discussed technologies that could help to address food and nutrition challenges while limiting climate change to 1.5 degree Celsius of warming. In his talk at the session, Eagle Genomics CEO Anthony Finbow made a case for microbiome science as a future driver of food system transformation.
“We don’t need to go into space to discover the new frontier,” Finbow said at the session. “We need to look within ourselves and within the soil to really understand how we are going to solve for climate change.”
That new frontier is in the human gut, where trillions of bacteria interact with human epithelial cells, sending signals to each other across a layer of mucus. And it’s in the rhizosphere, the dynamic space around a plant’s roots where microorganisms come to feed on nutrients produced by the plant, and provide protection from pathogens in exchange.
Symbiotic relationships between microbes and larger organisms are fundamental to life as we know it. According to Finbow, the importance of those relationships has long been overlooked. Now, however, “we’re seeing major enterprises across the world acknowledge the contribution of the microbiome and recognize its importance,” Finbow said.
Businesses are now unlocking microbial knowledge to improve human health, create safer products, and grow food crops more sustainably. DayTwo of Israel analyzes individuals’ microbiome data to provide personalized nutrition recommendations. Joyn Bio, a collaboration between Ginkgo Bioworks and Leaps by Bayer, is engineering improved microbial strains that can deliver more nitrogen to plants, cutting down on the need for fertilizers.
Eagle Genomics wants to become a network for businesses like these—as well as farms and research establishments—to collaborate and share data. The company’s cloud software platform uses network science, AI, and causal analysis to analyze microbes and their relationships to each other.
The company is currently working on its Series B raise, which Finbow estimated will amount to $30-50 million. They’ve received contracts from large enterprises for the use of their software platform, and have recently begun offering access to research establishments at a lower price point.
Throughout his presentation, Finbow was optimistic about the potential for microbial science to reconfigure our relationship with the environment and the way we think about human health.
“It is possible, by integrating the way we farm animals and grow plants in a way that nurtures the microecology in the soil, to actually reverse climate change—to actually start to capture more carbon and maintain that carbon within the soil,” Finbow said at the session. “It is possible for us, by engineering the microbiome of animals and ourselves, to live healthier lives and to subsist in a more sustaining environment.”
Leave a Reply